Several other blood-based liquid biopsies in development include circulating tumor cells (CTCs), microRNA (miRNA), long non-coding RNA (lncRNA), exosomes, and tumor-educated platelets (TEPs) that have the potential for diagnostics, prognostics, and predicting treatment resistance in EGFR mutated lung cancer [18–26]. Here, EGFR is linked to lung cancer.